[STARTUPS]■ STORY TIMELINE

MITHRL RAISES $20M FOR BIOPHARMA AI PLATFORM

Mithrl, an AI infrastructure company for pharmaceutical R&D, secured $20 million in Series A funding led by Obvious Ventures. The company integrates proprietary biomedical models directly into drug developers' research systems.

3 SOURCESFIRST SEEN SEP 19, 02:00 PM► READ THE ARTICLE

Techmeme+0m

Raindrop, which develops tech for monitoring AI agents to catch failures such as hallucinations and tool misuse, raised a $35M Series A led by CRV (Chris Metinko/Axios)

Chris Metinko / Axios: Raindrop, which develops tech for monitoring AI agents to catch failures such as hallucinations a…

Techmeme+1d 11h

Mithrl, which integrates its proprietary biomedical world model with the R&D systems of pharmaceutical companies, raised a $20M Series A led by Obvious Ventures (Natalie Breymeyer/Axios)

Natalie Breymeyer / Axios: Mithrl, which integrates its proprietary biomedical world model with the R&D systems of pharm…

Techmeme+1d 14h

Altis Labs, whose AI model analyzes CT scans taken during oncology trials and produces predictions tied to patient survival, has raised a $25M Series A (Natalie Breymeyer/Axios)

Natalie Breymeyer / Axios: Altis Labs, whose AI model analyzes CT scans taken during oncology trials and produces predic…

◄ BACK TO ARTICLE